Vestibular Schwannoma Causes
Vestibular Schwannoma Causes
A vestibular schwannoma arises from the Schwann cells that insulate the vestibular half of the hearing and balance nerve, and it grows where those cells are — in the canal at the base of the skull. What determines whether one appears is mostly a matter of chance in adults in midlife: no diet, habit or environmental exposure has been shown to cause it. The one clearly established risk factor is the inherited condition neurofibromatosis type 2, in which tumours arise on both hearing nerves; previous radiotherapy to the head at therapeutic doses is a rare further association.
Where the tumour comes from
The origin of the tumour explains both what it is and why it announces itself in the ear:
- It arises from Schwann cells — the cells that insulate the nerve fibres of the body. On the vestibular half of the eighth cranial nerve, those cells can overgrow into a benign tumour; the same biology produces schwannomas elsewhere in the body, which is why the name describes the cell rather than the organ.
- It starts in a canal of bone — at the inner end of the internal auditory canal, a passage the size of a fingertip carrying the hearing nerve, the balance nerve and the facial nerve. This is why small tumours already cause symptoms and why the anatomy dominates the treatment.
- It is a tumour of the nerve, not of the brain — it does not arise from brain tissue and does not invade it, which is why the treatment questions are about compression and protection rather than about margins and stages.
- It arises where the cells are, not where a cause was — there is nothing local to point to. The tumour appears on one side and not the other for reasons that are currently not understood, and no examination of the patient's history predicts which side.
Neurofibromatosis type 2
This is the one clearly established risk factor, and it deserves a precise account because it changes the whole pathway:
- What it is — an inherited condition caused by a change in the NF2 gene, which produces a protein that regulates the growth of Schwann cells. People with the condition develop tumours on both hearing nerves, usually in young adulthood, along with other tumours of the nervous system.
- How it announces itself here — bilateral vestibular schwannomas, one on each hearing nerve, are its hallmark. A tumour on both sides is therefore an indication for genetic assessment rather than a curiosity.
- What it changes — surveillance of both sides on a schedule, of the spine, and of the other nerves the condition can affect; treatment decisions that weigh two hearing nerves instead of one; and a genetics service that can talk to relatives.
- What it does not mean — that most vestibular schwannomas are inherited. The great majority are single, sporadic and occur in people with no family history; a diagnosis of NF2 is the exception, and it is suspected on findings rather than assumed.
Previous radiation to the head
This is a rare but established association, and it is worth understanding precisely what it means:
- What is established — people who received radiotherapy to the head at therapeutic doses, particularly in childhood, have a higher chance of developing schwannomas years later. The association is accepted rather than debated.
- What it does not mean — that diagnostic imaging causes these tumours. No link has been established between the doses used in CT or MRI and the development of a vestibular schwannoma.
- Why it still changes practice — because it is an exposure that can be limited. No necessary investigation should be avoided, but unnecessary examinations are not requested, and where radiotherapy is required the dose to normal tissue is planned deliberately.
- When it matters to the plan — a patient who has had previous radiotherapy to the head is followed with that history in mind, and a tumour arising in this setting is discussed with the whole team rather than treated on the standard pathway alone.
Why growth is unpredictable
Growth is the finding that the treatment decision turns on, and it is honest to say that no test at diagnosis predicts it well:
- What is known — many tumours grow slowly, some do not grow measurably at all over years, and a smaller share grows faster. The distribution is wide, and it is established by watching rather than by measuring once.
- What is associated with faster growth — younger age at diagnosis is the most consistent association; larger tumours also tend to have grown more. Neither predicts an individual tumour's behaviour with confidence.
- Why observation is the answer to uncertainty — precisely because growth cannot be predicted, it is measured. Scheduled scans convert an unknown into a known at intervals, and the treatment decision follows the measurement rather than a forecast.
- What this means for the first year — the intervals are closer at the start, when the tumour's behaviour is still unknown, and widen as the record accumulates. The first comparison is the most informative one the patient will have.
Explanations that are not supported
Several widely repeated explanations can be set aside, and doing so is useful because it redirects attention to what can be acted on:
- Mobile phones. Studied extensively because the phone is held against the ear, and no link has been established. The question has been examined in large populations over long periods, and the association does not hold.
- Head injury. A blow to the head does not cause a vestibular schwannoma. It sometimes leads to a scan that finds one, which is a different matter and a common source of the misunderstanding.
- Stress, diet and supplements. None has been shown to cause this tumour, and none has been shown to prevent or shrink it. Some supplements interfere with treatment, which makes taking them without discussion a real risk rather than a neutral choice.
- Infection and inflammation of the ear. These cause the same symptoms far more often than a tumour does — which is why the symptoms are usually investigated and usually benign — but chronic ear infection is not a cause of schwannoma.
- Occupational and environmental exposures. No occupation or environmental agent has been established as a cause, despite repeated studies.
Who is actually at risk
Putting the factors in one place, in order of how firmly they are established:
- People with neurofibromatosis type 2 — by far the highest-risk group, and the one with a defined surveillance programme.
- Adults in midlife — the great majority of sporadic tumours are diagnosed in this period, and part of the reason is simply that they have had time to grow large enough to be found.
- People who had therapeutic radiotherapy to the head, particularly in childhood — a small but real increase in risk, years later.
- People with a family history of the condition — a first-degree relative with neurofibromatosis type 2 warrants assessment; a relative with a single sporadic tumour does not, because that is not a hereditary event.
- Everyone else — no lifestyle, occupational or environmental factor has been shown to change the risk, and nothing a person did or failed to do brought the tumour about.